Muscular Dystrophy Treatment Market Primed to Achieve Steady Growth Due to Rising Prevalence of Chronic Genetic Disorders



Muscular dystrophies are a group of inherited genetic disorders that progressively weaken and damage muscles of voluntary movement in the body. The rising incidence of genetic disorders and the launch of novel gene therapies are driving widespread interest in developing more effective treatments for muscular dystrophies.

The Muscular Dystrophy Treatment Market is estimated to be valued at US$ 2.30 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030.

Key Takeaways

Key players operating in the Muscular Dystrophy Treatment Market are F. Hoffmann-La Roche AG, PTC Therapeutics, Sarepta Therapeutics, and others. Key players are investing heavily in R&D to develop advanced gene therapies and molecular treatments for muscular dystrophies.

The emerging field of gene and genetic therapies holds potential opportunities to develop curative treatments for various forms of muscular dystrophy. Several gene therapy candidates are under development which could transform the treatment landscape in the coming years.

The Muscular Dystrophy Treatment Market is set to witness significant expansion in key global markets as major players focus on expanding access through partnerships and collaborations. Strategic collaborations with biotech companies and hospitals are enabling wider reach and adoption of new therapeutic agents.

Market Drivers
Rising prevalence of genetic muscular disorders is a key driver fueling market growth. According to the Muscular Dystrophy Association, nearly 1 in 5,000 newborn babies have a type of muscular dystrophy. Robust R&D activity and new product launches. Major companies are investing heavily in clinical trials for gene therapies and molecular treatments, which is also facilitating market expansion.

Market Restraints
High costs involved in development of advanced gene therapies and molecular treatments pose a restraint for market growth. Gene therapies for rare diseases can cost millions of dollars. Muscular dystrophies being rare genetic disorders also limits the commercial viability of such high-cost treatments initially.


Segment Analysis
The muscular dystrophy treatment market is segmented based on type, route of administration, end-user and distribution channel. By type, the duchenne muscular dystrophy segment holds the largest market share due to increasing prevalence rates. Duchenne muscular dystrophy is the most common and severe form of muscular dystrophy and largely affects children. By route of administration, the oral segment dominates the market as oral drugs are more convenient and easy to administer. Hospitals are the major end-users in the muscular dystrophy treatment market as most patients undergo treatment in hospitals. The hospital pharmacy distribution channel holds the largest share as hospital pharmacies offer drugs required for long-term therapies.

Global Analysis
North America holds the largest share in the global muscular dystrophy treatment market due to growing cases of the disease and increasing technological innovation. The US leads the North American market due to major pharmaceutical companies and rising healthcare expenditure. Europe is the second largest market due to growing government support and increasing healthcare infrastructure. Asia Pacific is the fastest growing region on account of improving healthcare infrastructure, increased diagnosis rates and growing medical tourism. Changes in lifestyle, increasing healthcare expenditures and rising prevalence of genetic disorders contribute to the Asia Pacific market growth.

Comments

Post a Comment

Popular posts from this blog

Neuroendocrine Cancer is the fastest growing segment fueling the growth of Pituitary Cancer Market

Image
The pituitary cancer market comprises of medical treatment options for patients diagnosed with pituitary cancer. Pituitary cancers are rare tumors that start in the pituitary gland which is a pea-sized gland located at the base of the brain.  The global Pituitary Cancer Market is estimated to be valued at US$ 380.7 Mn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.    Market key trends: One of the key trends fueling the growth of the pituitary cancer market is rising preference of targeted drug therapy over conventional chemotherapy. Targeted drug therapies mainly include somatostatin analogs and dopamine agonists which directly act on cancer cells and have less side effects compared to chemotherapy. These targeted drugs are effective in controlling symptoms and slowing tumor growth in patients with hormone secreting pituitary adenomas and carcinomas. The targe...
Read more

Enhancing Patient Care and Comfort: The Evolution of Hospital Beds

Image
  Hospital beds play a crucial role in patient care, providing comfort, safety, and functionality for individuals requiring medical attention. Over the years, advancements in technology and design have revolutionized hospital beds, leading to improved patient outcomes and caregiver efficiency. From basic adjustable beds to sophisticated models equipped with cutting-edge features, the evolution of hospital beds has transformed the healthcare landscape. Evolution of Hospital Beds: Historically, hospital beds were simple in design, primarily consisting of a metal frame with adjustable height and manual controls. However, as medical practices advanced and patient needs became more complex, the demand for more versatile and ergonomic hospital beds grew. In recent decades, significant strides have been made in the development of hospital bed technology. Modern hospital beds are designed with a focus on patient comfort, safety, and mobility. Features such as electronic controls, motorize...
Read more

Dry Eye Disease Market is Estimated to Witness High Growth Owing to Rising Awareness About Disease Management

Image
  Dry eye disease, also known as keratoconjunctivitis sicca, is a multifactorial disease of the ocular surface characterized by lack of sufficient moisture and tear film instability. Common symptoms of dry eye include stingy or burning sensation in eyes and blurred vision.   Market Dynamics : The Dry Eye Disease Market is witnessing high growth owing to rising awareness about disease management and increasing number of people experiencing symptoms of dry eyes. According to the report, increasing usage of electronic devices and prolonged screen time is a major driver fueling the demand for dry eye treatments. Additionally, growing geriatric population worldwide who are more prone to dry eyes is also contributing to the market growth. Availability of various treatment options along with new product launches is further expected to boost the market during forecast period.   Increasing Prevalence of Dry Eye Disease is Driving Market Growth   One of the major market drive...
Read more